Aspiriant LLC’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$500K Hold
4,493
0.01% 221
2025
Q4
$502K Hold
4,493
0.01% 213
2025
Q3
$488K Hold
4,493
0.01% 201
2025
Q2
$453K Hold
4,493
0.01% 207
2025
Q1
$415K Buy
+4,493
New +$438K 0.01% 202

Other funds holding AVUS

Aspiriant LLC's AVUS Position: Q1 2026 in Review

Aspiriant LLC held its Avantis US Equity ETF (AVUS) position steady in Q1 2026 at 4,493 shares worth $500K. The position accounts for 0.01% of the portfolio, ranked #221.

Aspiriant LLC first reported a position in AVUS in Q1 2025 and has held it in 5 quarters since. The position peaked at $502K in Q4 2025. 553 funds tracked by Wall St. Rank hold AVUS as of Q1 2026.

  • Aspiriant LLC held 4,493 shares of Avantis US Equity ETF worth $500K as of Q1 2026.
  • Aspiriant LLC left its Avantis US Equity ETF share count unchanged in Q1 2026.
  • Avantis US Equity ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #221 holding.
  • Aspiriant LLC first reported a position in Avantis US Equity ETF in Q1 2025 and has held it in 5 quarters since.
  • Aspiriant LLC's Avantis US Equity ETF position peaked at $502K in Q4 2025.
  • 553 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.